Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

Standard

Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. / Jeldres, Claudio; Suardi, Nazareno; Walz, Jochen; Saad, Fred; Hutterer, Georg C; Bhojani, Naeem; Shariat, Shahrokh F; Perrotte, Paul; Graefen, Markus; Montorsi, Francesco; Karakiewicz, Pierre I.

in: EUR UROL, Jahrgang 54, Nr. 1, 1, 2008, S. 107-116.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Jeldres, C, Suardi, N, Walz, J, Saad, F, Hutterer, GC, Bhojani, N, Shariat, SF, Perrotte, P, Graefen, M, Montorsi, F & Karakiewicz, PI 2008, 'Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.', EUR UROL, Jg. 54, Nr. 1, 1, S. 107-116. <http://www.ncbi.nlm.nih.gov/pubmed/17996358?dopt=Citation>

APA

Jeldres, C., Suardi, N., Walz, J., Saad, F., Hutterer, G. C., Bhojani, N., Shariat, S. F., Perrotte, P., Graefen, M., Montorsi, F., & Karakiewicz, P. I. (2008). Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men. EUR UROL, 54(1), 107-116. [1]. http://www.ncbi.nlm.nih.gov/pubmed/17996358?dopt=Citation

Vancouver

Bibtex

@article{ff410c45711648309a5c78d7def494b1,
title = "Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.",
abstract = "OBJECTIVES: The life expectancy of candidates for attempted curative therapy of prostate cancer should not be inferior to 10 yr. We examined the rate of 10-yr survival in septa- and octogenarians treated for prostate cancer with either attempted curative external beam radiotherapy (EBRT) or radical prostatectomy (RP). METHODS: Within a population-based cohort of 17,570 EBRT or RP patients, 6183 men aged 70 yr or older were treated with either RP (n=1591) or EBRT (n=4592) and represented the focus of crude survival analyses. Age and Charlson Comorbidity Index represented covariates. To control for prostate cancer-specific mortality, we repeated the analyses in a subset of 2704 men (RP, n=881; EBRT, n=1823) who had no clinical evidence of disease relapse of prostate cancer. RESULTS: Overall actuarial 10-yr survival was 38.5% (RP 59.3% vs. EBRT 30.3%, p",
author = "Claudio Jeldres and Nazareno Suardi and Jochen Walz and Fred Saad and Hutterer, {Georg C} and Naeem Bhojani and Shariat, {Shahrokh F} and Paul Perrotte and Markus Graefen and Francesco Montorsi and Karakiewicz, {Pierre I}",
year = "2008",
language = "Deutsch",
volume = "54",
pages = "107--116",
journal = "EUR UROL",
issn = "0302-2838",
publisher = "Elsevier",
number = "1",

}

RIS

TY - JOUR

T1 - Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

AU - Jeldres, Claudio

AU - Suardi, Nazareno

AU - Walz, Jochen

AU - Saad, Fred

AU - Hutterer, Georg C

AU - Bhojani, Naeem

AU - Shariat, Shahrokh F

AU - Perrotte, Paul

AU - Graefen, Markus

AU - Montorsi, Francesco

AU - Karakiewicz, Pierre I

PY - 2008

Y1 - 2008

N2 - OBJECTIVES: The life expectancy of candidates for attempted curative therapy of prostate cancer should not be inferior to 10 yr. We examined the rate of 10-yr survival in septa- and octogenarians treated for prostate cancer with either attempted curative external beam radiotherapy (EBRT) or radical prostatectomy (RP). METHODS: Within a population-based cohort of 17,570 EBRT or RP patients, 6183 men aged 70 yr or older were treated with either RP (n=1591) or EBRT (n=4592) and represented the focus of crude survival analyses. Age and Charlson Comorbidity Index represented covariates. To control for prostate cancer-specific mortality, we repeated the analyses in a subset of 2704 men (RP, n=881; EBRT, n=1823) who had no clinical evidence of disease relapse of prostate cancer. RESULTS: Overall actuarial 10-yr survival was 38.5% (RP 59.3% vs. EBRT 30.3%, p

AB - OBJECTIVES: The life expectancy of candidates for attempted curative therapy of prostate cancer should not be inferior to 10 yr. We examined the rate of 10-yr survival in septa- and octogenarians treated for prostate cancer with either attempted curative external beam radiotherapy (EBRT) or radical prostatectomy (RP). METHODS: Within a population-based cohort of 17,570 EBRT or RP patients, 6183 men aged 70 yr or older were treated with either RP (n=1591) or EBRT (n=4592) and represented the focus of crude survival analyses. Age and Charlson Comorbidity Index represented covariates. To control for prostate cancer-specific mortality, we repeated the analyses in a subset of 2704 men (RP, n=881; EBRT, n=1823) who had no clinical evidence of disease relapse of prostate cancer. RESULTS: Overall actuarial 10-yr survival was 38.5% (RP 59.3% vs. EBRT 30.3%, p

M3 - SCORING: Zeitschriftenaufsatz

VL - 54

SP - 107

EP - 116

JO - EUR UROL

JF - EUR UROL

SN - 0302-2838

IS - 1

M1 - 1

ER -